Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Eukaryotic Gene Expression
Factor de Impacto: 1.841 Factor de Impacto de 5 años: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Imprimir: 1045-4403
ISSN En Línea: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2017019712
pages 229-236

Role of Interleukin-6 in Development of Insulin Resistance and Type 2 Diabetes Mellitus

Kanwal Rehman
Institute of Pharmacy, Physiology and Pharmacology, University of Agriculture, Faisalabad, Pakistan
Muhammad Sajid Hamid Akash
Department of Pharmaceutical Chemistry, Government College University Faisalabad, Pakistan
Aamira Liaqat
Department of Pharmaceutical Chemistry, Government College University Faisalabad, Pakistan; Department of Biochemistry, Government College University Faisalabad, Pakistan
Shagufta Kamal
Department of Biochemistry, Government College University Faisalabad, Pakistan
Muhammad Imran Qadir
Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Bosan Road, Multan, Pakistan
Akhtar Rasul
Department of Pharmaceutics, Government College, University Faisalabad, Pakistan

SINOPSIS

Interleukin-6 (IL-6) is a proinflammatory cytokine that decisively induces the development of insulin resistance and pathogenesis of type 2 diabetes mellitus (T2DM) through the generation of inflammation by controlling differentiation, migration, proliferation, and cell apoptosis. The presence of IL-6 in tissues is a normal consequence, but its irregular production and long-term exposure leads to the development of inflammation, which induces insulin resistance and overt T2DM. There is a mechanistic relationship between the stimulation of IL-6 and insulin resistance. IL-6 causes insulin resistance by impairing the phosphorylation of insulin receptor and insulin receptor substrate-1 by inducing the expression of SOCS-3, a potential inhibitor of insulin signaling. In this article, we have briefly described how IL-6 induces the insulin resistance and pathogenesis of T2DM. The prevention of inflammatory disorders by blocking IL-6 and IL-6 signaling may be an effective strategy for the treatment of insulin resistance and T2DM.


Articles with similar content:

Role of the D Prostanoid Receptor 1 in the Modulation of Immune and Inflammatory Responses
Critical Reviews™ in Immunology, Vol.24, 2004, issue 5
Christelle Faveeuw, Philippe Gosset, Veronique Angeli, Francois Trottein
Regulation of Chondrocytic Gene Expression by Biomechanical Signals
Critical Reviews™ in Eukaryotic Gene Expression, Vol.18, 2008, issue 2
Sudha Agarwal, Shashi Madhavan, Jin Nam, Suresh Agarwal, Jr., Thomas J. Knobloch
Inhibition of STAT3 Activation by RKIP in Colon Cancer
Forum on Immunopathological Diseases and Therapeutics, Vol.2, 2011, issue 1
Devasis Chatterjee, Erika L. Moen, Y. Eugene Chin
Cell survival and proliferation signaling pathways are downregulated by plasma-activated medium in glioblastoma brain tumor cells
Plasma Medicine, Vol.2, 2012, issue 4
Masaru Hori, Hiromasa Tanaka, Hiroaki Kajiyama, Shoichi Maruyama, Kenji Ishikawa, Masaaki Mizuno, Hiroyuki Kano, Fumi Utsumi, Kae Nakamura, Fumitaka Kikkawa
Nitric Oxide-Mediated Regulation of Cancer Immune Escape
Forum on Immunopathological Diseases and Therapeutics, Vol.1, 2010, issue 4
D. Robert Siemens, Charles H. Graham